| PCS-2023 > 3 > 3E > 3E0 > 3E0K |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0K | Introduction, Genitourinary Tract | |
3E0K3 | Percutaneous | |
3E0K30 | Antineoplastic | |
3E0K304 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach | |
3E0K305 | Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach | |
3E0K30M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach | |
3E0K32 | Anti-infective | |
3E0K328 | Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach | |
3E0K329 | Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach | |
3E0K33 | Anti-inflammatory | |
3E0K33Z | Introduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach | |
3E0K36 | Nutritional Substance | |
3E0K36Z | Introduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach | |
3E0K37 | Electrolytic and Water Balance Substance | |
3E0K37Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach | |
3E0K3B | Anesthetic Agent | |
3E0K3BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach | |
3E0K3H | Radioactive Substance | |
3E0K3HZ | Introduction of Radioactive Substance into Genitourinary Tract, Percutaneous Approach | |
3E0K3K | Other Diagnostic Substance | |
3E0K3KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Percutaneous Approach | |
3E0K3N | Analgesics, Hypnotics, Sedatives | |
3E0K3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Percutaneous Approach | |
3E0K3T | Destructive Agent | |
3E0K3TZ | Introduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach | |
3E0K3G | Other Therapeutic Substance | |
3E0K3GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach | |
3E0K3S | Gas | |
3E0K3SF | Introduction of Other Gas into Genitourinary Tract, Percutaneous Approach | |
3E0K7 | Via Natural or Artificial Opening | |
3E0K70 | Antineoplastic | |
3E0K704 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K705 | Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K70M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K72 | Anti-infective | |
3E0K728 | Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K729 | Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K73 | Anti-inflammatory | |
3E0K73Z | Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K76 | Nutritional Substance | |
3E0K76Z | Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K77 | Electrolytic and Water Balance Substance | |
3E0K77Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7B | Anesthetic Agent | |
3E0K7BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7H | Radioactive Substance | |
3E0K7HZ | Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7K | Other Diagnostic Substance | |
3E0K7KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7N | Analgesics, Hypnotics, Sedatives | |
3E0K7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7T | Destructive Agent | |
3E0K7TZ | Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7G | Other Therapeutic Substance | |
3E0K7GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K7S | Gas | |
3E0K7SF | Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening | |
3E0K8 | Via Natural or Artificial Opening Endoscopic | |
3E0K80 | Antineoplastic | |
3E0K804 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K805 | Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K80M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K82 | Anti-infective | |
3E0K828 | Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K829 | Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K83 | Anti-inflammatory | |
3E0K83Z | Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K86 | Nutritional Substance | |
3E0K86Z | Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K87 | Electrolytic and Water Balance Substance | |
3E0K87Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8B | Anesthetic Agent | |
3E0K8BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8H | Radioactive Substance | |
3E0K8HZ | Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8K | Other Diagnostic Substance | |
3E0K8KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8N | Analgesics, Hypnotics, Sedatives | |
3E0K8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8T | Destructive Agent | |
3E0K8TZ | Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8G | Other Therapeutic Substance | |
3E0K8GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K8S | Gas | |
3E0K8SF | Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | |
3E0K4 | Percutaneous Endoscopic | |
3E0K4G | Other Therapeutic Substance | |
3E0K4GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Endoscopic Approach | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |